No Preferential Sensitivity of t(8;21) Acute Myeloid Leukemias to Cytosine Arabinoside in Vitro: Is Intensity of Therapy or High Dose Ara-C Crucial for Response?

Reference

• Hagemeijer, A., Garson, O.M. and Kondo, K. (1984) "Fourth International Workshop on Chromosomes in Leukemia 1982: Translocation (8;2I)(q22;q22) in acute nonlymphocytic leukemia", Cancer Genet. Cytogenet., 11(3), 284–287.
   Google Scholar
• Miyoshi, H., Shimizu, K., Kozu, T., Maseki, N., Kaneko, Y. and Ohlci, M. (1991) "t(8;21) Breakpoints on Chromosome 21 in Acute Myeloid Leukemia are Clustered within a Limited Region of a Single Gene, AML I", Proc. Natl. Acad. Sci. USA, 88, 10431 — 10434.
   PubMed Web of Science ®Google Scholar
• Shimizu, K., Miyoshi, H., Kozu, T., Nagata, J., Enomoto, K., Maseki, N., et al. (1992) "Consistent distruption of the AMLI gene occurs within a single intron in the t(8;21) chromosomal transloca-tion", Cancer Res., 52(24), 6945–6948.
   PubMed Web of Science ®Google Scholar
• Erikson, P., Gao, J., Chang, K.S., Look, T., Whisenant, E., Raimondi, S., et al. (1992) "Identification of breakpoints in t(8;21) acute myeloid leukemia and isolation of a fusion transcript, AML I/ ETO, with similarity to drosophila segmentation gene, runt", Blood, 80(7), 1825–1831.
   PubMed Web of Science ®Google Scholar
• Dastague, N., Payen, C., Lafage-Pochitaloff, M., Bernard, P., Lerous, D., Huguet-Rigal, F., et al. (1995) "Prognostic significance of karyotype in de novo adult myeloid leukemia", Leukemia, 9, 1491–1498.
   PubMed Web of Science ®Google Scholar
• Stasi, R., Del Poeta, G. and Masi, M. (1993) "Incidence of chromosome abnormalities and clinical significance of karyotype in de novo acute myeloid leukemia", Cancer Genet. Cytogenet., 167, 28–34.
   Google Scholar
• Schiffer, C.A., Lee, E.J. and Tomiyasu, T. (1989) "Prognostic impact of cytogenetic abnormalities in patients with de novo acute nonlymphocytic leukemia", Blood, 73, 263–270.
   Google Scholar
• Keating, M.J., Smith, T.L. and Kantarjian, H.M. (1988) "Cytoge-netic pattern of acute myelogenous leukemia: A major reproducible determinate of outcome", Leukemia, 2, 403–412.
   PubMed Web of Science ®Google Scholar
• Bloomfield, C.D., Shuma, C., Regal, L., Philip, P.P., Hossfeld, D.K., Hagemeijer, A.M., et al. (1997) "Long-term survival of patients with acute myeloid leukemia. A third follow-up of the Fourth International Workshop on Chromosomes in Leukemia", Cancer, 80, 2191 — 2198.
   Google Scholar
• Bloomfield, CD., Lawrence, D., Byrd, J.C., Carroll, A., Pettenati, M.J., Tantravahi, R., et al. (1998) "Frequency of prolonged remission duration after high-dose cytarabine intensification in acute myeloid leukemia varies by cytogenetic subtype", Cancer Res., 62(24), 7372–7376.
   Google Scholar
• Byrd, J.C., Dodge, R.K., Carroll, A., Baer, MR., Edwards, C., Stamberg, J., et al. (1999) "Patients with t(8;2I)(q22;q22) and acute myeloid leukemia have superior failure-free and overall survival when repetitive cycles of high-dose cytarabine are administered", J. Clin. OncoL, 17(12), 3767 — 3775.
   Web of Science ®Google Scholar
• Wolff, S.N., Herzig, R.H. and Fay, J.W. (1989) "High-dose cytarabine and daunorubicin as consolidation therapy for acute myeloid leukemia in first remission: Long-term follow-up and results", J. Clin. OncoL, 7, 1260–1267.
   Web of Science ®Google Scholar
• Mayer, R.J., Davis, R.B. and Schiffer, C.A. (1994) "Intensive post-remission chemotherapy in adults with acute myeloid leukemia", N. Engl. J. Med., 334, 896–903.
   Google Scholar
• Hannun, V.A. (1997) "Apoptosis and the dilemma of cancer chemotherapy", Blood, 89, 1845 — 1853.
   Google Scholar
• Gunji, H., Kharbanda, S. and Kufe, D. (1991) "Induction of internucleosomal DNA fragmentation in human myeloid leukemia cells by 1-fl-D-arabinofuranosylcytosine", Blood, 100(13), 4609 — 4614.
   Google Scholar
• Grant, S. (1988) "AraC: cellular and molecular pharmacology", Adv. Cancer Res., 72, 197–233.
   Google Scholar
• Kaufmann, S.H. (1989) "Induction of endonucleolitic DNA cleavage in human acute myelogenous leukemia cells by etoposide, camptothecin and other cytotoxic anticancer drugs", Cancer Res., 49, 5870–5878.
   PubMed Web of Science ®Google Scholar
• Tosi, P., Visani, G., Ottaviani, E., Testoni, N., Pellacani, A. and Tura, S. (1998) "Inv(I6) acute myeloid leukemia cells show an increased sensitivity to cytosine arabinoside in vitro", Eur. J. Haematol., 60, 161–165.
   PubMed Web of Science ®Google Scholar
• Darzynlcievicicz, Z., Bruno, S., Del Bino, G., Gorczyca, W., Hotz, M.A., Lassotas, P., et al. (1992) "Features of apoptotic cells measured by flow cytometry", Cytometry, 13, 797–808.
   Google Scholar
• Larson, R.A., Le Beau, MM., Vardiman, J.W., Testa, J.R., Golomb, H.M. and Rowley, J.D. (1983) "The predictive value of initial cytogenetic studies in 148 adults with acute non-lymphocytic leukemia: a 12 year study (1970-1982)", Cancer Genetic Cytoge-netic, 10, 219–236.
   PubMed Web of Science ®Google Scholar
• Arthur, D.C., Berger, R., Golomb, H.M., Swansbury, G.J., Reeves, BR., Alimena, G., et al. (1989) "The clinical significance of karyotype in acute myelogenous leukemia. Sixth International Workshop on Chromosomes in Leukemia", Cancer Genet. Cyto-genet., 40(2), 203–216.
   Web of Science ®Google Scholar
• Bloomfield, C.D., Shuma, C. and Regal, L. (1997) "Long-term survival of patients with acute myeloid leukemia", Cancer, 80, 2191–2198.
   Google Scholar
• Mrözek, K., Heinonen, K. and de la Chapelle, A. (1997) "Clinical significance of cytogenetics in acute myeloid leukemia", Semin. OncoL, 24, 17–31.
   PubMed Web of Science ®Google Scholar
• Grimwade, D., Walker, H., Oliver, F., Wheatley, K., Harrison, C., Harrison, G., et al. (1998) "The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukemia Working Parties", Blood, 92(7), 2322 — 2333.
   Google Scholar
• Visani, G., Bernasconi, P., Boni, M., Castoldi, G.L., Ciolli, S., Clavio, M., et al. (2001) "The prognostic value of cytogenetic is reinforced by the kind of induction/consolidation therapy in influencing the outcome of acute myeloid leukemia — analysis of 848 patients", Leukemia, 15, 903–909.
   PubMed Web of Science ®Google Scholar
• Nguyen, S., Leblanc, T., Fenawc, P., Witz, F., Blaise, D., Pignewc, A., et al. (2002) "A white blood cell index as the main prognostic factor in t(8;21) acute myeloid leukemia (AML): a survey of 161 cases from the French AML Intergroup", Blood, 99(10), 3517 — 3523.
   PubMed Web of Science ®Google Scholar